
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    Okay, I will analyze the provided list of highly expressed markers from a single-cell RNA sequencing cluster from human large intestine tissue to identify the cell type.<br><br>**Step 1: List the Key Functional Markers**<br><br>This cluster shows high expression of several genes encoding hormones, neuropeptides, and enzymes involved in their synthesis and processing, indicating a secretory, likely endocrine, function.<br><br>*   **GCG (Glucagon):** While primarily known for its role in glucose regulation from pancreatic alpha cells, GCG is also produced by intestinal L cells and acts as a gut hormone.<br>*   **PYY (Peptide YY):** A gut hormone produced predominantly by L cells in the ileum and colon, involved in regulating appetite and gut motility.<br>*   **INSL5 (Insulin-like peptide 5):** Another peptide hormone produced by L cells, implicated in gut motility and appetite regulation.<br>*   **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone family, found in various endocrine cells, including some enteroendocrine subtypes.<br>*   **SCT (Secretin):** A gut hormone produced by S cells, primarily in the duodenum and jejunum, stimulating bicarbonate secretion. Its presence here suggests potential S cells or overlap.<br>*   **PCSK1 (Proprotein convertase subtilisin/kexin type 1):** An enzyme involved in the post-translational processing of prohormones and neuropeptides into their active forms. Highly expressed in neuroendocrine cells.<br>*   **TPH1 (Tryptophan hydroxylase 1):** The rate-limiting enzyme in the synthesis of serotonin (5-hydroxytryptamine). A key marker for enterochromaffin (EC) cells.<br>*   **SLC18A1 (Solute carrier family 18 member A1):** Also known as VMAT1 (Vesicular Monoamine Transporter 1), responsible for packaging monoamines like serotonin into vesicles for secretion. Another key marker for EC cells.<br><br>**Step 2: List the Key Cell Type Markers**<br><br>The marker list includes several genes characteristic of neuroendocrine cells and specific enteroendocrine subtypes, as well as transcription factors involved in their development.<br><br>*   **General Neuroendocrine Markers:**<br>    *   **CHGA (Chromogranin A):** A ubiquitous marker for neuroendocrine cells, involved in the storage and release of hormones and peptides.<br>    *   **CHGB (Chromogranin B):** Another chromogranin, also a general marker for neuroendocrine cells.<br>    *   **SCG2 (Secretogranin II), SCG3 (Secretogranin III), SCG5 (Secretogranin V):** Members of the secretogranin family, involved in the processing and storage of hormones and peptides in secretory granules. Common in neuroendocrine cells.<br>    *   **SNAP25 (Synaptosomal-associated protein 25):** A component of the SNARE complex involved in vesicle fusion and exocytosis, characteristic of neurons and neuroendocrine cells.<br>    *   **CPLX2 (Complexin 2):** A protein that regulates SNARE-mediated vesicle fusion, found in neuroendocrine cells.<br>    *   **SCGN (Secretagogin):** A calcium-binding protein found in neuroendocrine cells, potentially involved in calcium-regulated exocytosis.<br>    *   **PRPH (Peripherin), INA (Internexin neuronal intermediate filament protein alpha):** Intermediate filament proteins found in neurons and some neuroendocrine cells.<br>*   **Transcription Factors:**<br>    *   **FEV (FEV transcription factor):** Involved in the development and differentiation of specific enteroendocrine cells, including EC and L cells.<br>    *   **NKX2-2 (NK2 homeobox 2):** A transcription factor crucial for the development of various endocrine cell types, including enteroendocrine cells.<br>    *   **INSM1 (Insulinoma-associated protein 1):** A key transcription factor required for the differentiation of neuroendocrine cells.<br>    *   **RFX6 (Regulatory factor X6):** A transcription factor essential for the development of pancreatic and intestinal endocrine cells.<br>    *   **ARX (Aristaless related homeobox):** A transcription factor involved in the development of various endocrine cells, including pancreatic alpha cells and intestinal L cells.<br>*   **Other Potential Markers:**<br>    *   **LCN15 (Lipocalin 15):** Less commonly cited as a primary enteroendocrine marker, but sometimes associated with gut epithelium.<br>    *   **SLC5A8 (Solute carrier family 5 member 8):** A sodium-coupled monocarboxylate transporter, found in colonocytes and potentially some enteroendocrine cells, involved in transporting short-chain fatty acids.<br><br>**Step 3: Cross-reference Known Databases**<br><br>Cross-referencing these markers with established scRNA-seq datasets of the human large intestine (e.g., Human Cell Atlas, specific gut scRNA-seq studies) and relevant literature confirms that the co-expression of general neuroendocrine markers (CHGA, SCG*, PCSK1, INSM1) along with specific hormone/peptide markers (GCG, PYY, INSL5, TPH1, SCT) and transcription factors (FEV, NKX2-2, RFX6, ARX) is characteristic of enteroendocrine cells. The specific combination and ranking of markers point towards particular subtypes.<br><br>**Step 4: Determine the Most Probable General Cell Type**<br><br>Based on the strong and consistent expression of general neuroendocrine markers (CHGA, CHGB, SCG*, PCSK1, SNAP25, INSM1) and the presence of multiple gut hormones/peptides and their synthesis machinery (GCG, PYY, INSL5, TPH1, SLC18A1, SCT, PCSK1), the most probable general cell type is **Enteroendocrine cells**.<br><br>**Step 5: Identify the Top 3 Most Probable Sub Cell Types**<br><br>The cluster expresses markers associated with multiple enteroendocrine subtypes. Based on the ranking and specificity of the markers:<br><br>1.  **L cells:** High expression of GCG, PYY, and INSL5, which are canonical markers for L cells, particularly abundant in the large intestine. FEV and ARX are also associated with L cell development.<br>2.  **Enterochromaffin (EC) cells:** High expression of TPH1 and SLC18A1 (VMAT1), which are specific markers for EC cells responsible for serotonin production. FEV is also associated with EC cells.<br>3.  **S cells:** Expression of SCT, the marker for S cells. While S cells are primarily found in the upper small intestine, they are present at lower frequencies in the large intestine.<br><br>Given the very high ranking of L cell markers (GCG, PYY, INSL5) and the significant presence of EC cell markers (TPH1, SLC18A1), this cluster likely represents a population enriched for L cells but also containing or co-expressing markers of EC cells. The presence of SCT suggests a minor contribution from S cells or potential marker overlap/plasticity.<br><br>Based on the prominence and ranking of the markers, the most likely subtype is **L cells**, with a significant contribution or overlap from Enterochromaffin (EC) cells.<br><br>**Step 6: Provide a Concise Summary of Your Analysis**<br><br>This cell cluster from the human large intestine is confidently identified as **Enteroendocrine cells** due to the high expression of general neuroendocrine markers such as CHGA, PCSK1, SCG*, INSM1, and SNAP25. Further analysis of specific hormone and synthesis markers reveals a strong signal for **L cells** (GCG, PYY, INSL5) and a significant signal for **Enterochromaffin (EC) cells** (TPH1, SLC18A1). The presence of SCT suggests a potential minor component of S cells or marker co-expression. Based on the ranking of specific markers, the cluster is most likely composed of **L cells**, potentially with co-expression of EC markers or representing a mixed population of L and EC cells.<br><br>FINAL ANNOTATION COMPLETED.
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Enteroendocrine cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>L cells</li><li>Enterochromaffin (EC) cells</li><li>S cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li>L and EC cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">92</div>
                        <div class="scoring-content">
                            The annotation results provided are scientifically accurate and well-supported by the markers listed. The analysis correctly identifies the cluster as **Enteroendocrine cells**, which is justified by the presence of general neuroendocrine markers such as **CHGA**, **CHGB**, **SCG family genes**, **PCSK1**, and **INSM1**. The annotation further refines this to specific subtypes, primarily **L cells** (marked by **GCG**, **PYY**, and **INSL5**) and **Enterochromaffin (EC) cells** (marked by **TPH1** and **SLC18A1**), with a minor mention of **S cells** (marked by **SCT**). This aligns with known literature and scRNA-seq datasets for the human large intestine.<br><br>**Strengths:**<br>1. **Comprehensive Marker Analysis:** The annotation considers a wide range of markers, including hormones, neuropeptides, processing enzymes, and transcription factors, providing a holistic view of the cell type. For example, the inclusion of **FEV**, **NKX2-2**, and **RFX6** as transcription factors supports the developmental context of enteroendocrine cells.<br>2. **Subtype Differentiation:** The annotation distinguishes between L cells and EC cells based on the prominence of their respective markers (e.g., **GCG** for L cells and **TPH1** for EC cells). This is well-reasoned and reflects the heterogeneity within enteroendocrine populations.<br>3. **Rank Consideration:** The analysis acknowledges the ranking of markers (e.g., **GCG** appearing early in the list), which is critical for interpreting scRNA-seq data where marker expression levels matter.<br>4. **Validation:** The annotation references cross-referencing with established databases (e.g., Human Cell Atlas), adding credibility to the conclusions.<br><br>**Weaknesses:**<br>1. **Minor Oversight in Subtype Specificity:** While the annotation mentions **S cells**, their primary marker (**SCT**) is less prominent in the large intestine compared to the small intestine. The analysis could have explicitly noted this rarity or potential artifact.<br>2. **Handling of Mixed Populations:** The annotation suggests a possible mixed population of L and EC cells but does not explore whether this could represent transitional states or technical noise (e.g., doublets). A deeper discussion on this aspect would strengthen the analysis.<br>3. **Less Common Markers:** Some markers (e.g., **LCN15**, **SLC5A8**) are briefly mentioned but not thoroughly contextualized. While they may not be primary markers, their inclusion without explanation could confuse less experienced readers.<br><br>**Overall,** the annotation is highly accurate and captures the general picture of the cell populations effectively. The minor weaknesses do not detract significantly from the overall correctness and utility of the results.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    